Indywidualna Specjalistyczna Praktyka Lekarska Wiesław Jerzy Cubała
- Address
- lock Available on a paid plan
Indywidualna Specjalistyczna Praktyka Lekarska Wiesław Jerzy Cubała - Advanced Psychiatric Research Center
This specialized psychiatric practice focuses on cutting-edge clinical research in severe mental health disorders, particularly in the treatment of challenging psychiatric conditions that require innovative therapeutic approaches. The center demonstrates expertise in complex psychiatric pharmacotherapy and participates in advanced multi-phase clinical investigations.
- Treatment-resistant schizophrenia and novel pharmacological interventions
- Add-on therapy strategies for refractory psychiatric conditions
- Dose-finding studies and adaptive clinical trial methodologies
The practice specializes in evaluating residual symptoms in refractory schizophrenia, with particular emphasis on patients treated with clozapine. Through participation in sophisticated adaptive phase II/III trials, the center contributes to the development of innovative therapeutic agents such as D-Amino Acid Oxidase inhibitors, advancing treatment options for patients with the most challenging psychiatric conditions who have not adequately responded to standard therapies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Indywidualna Specjalistyczna Praktyka Lekarska Wiesław Jerzy Cubała
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Sodium Benzoate as an Adjunct to Clozapine for Residual Symptoms in Refractory Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study | Syneurx International (Taiwan) Corp. | Phase IV | Recruiting | Nov 2019 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| SODIUM BENZOATE | 1 | Unknown | 2019-11-26 | 2019-11-26 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.